People with a history of pancreatitis or severe gastrointestinal disorders may not be good candidates and generally should avoid GLP-1 therapy unless cleared by a specialist, given the potential risks
Kristi Kratovil, clinical lead for obesity medicine at Sentara Health
Meet Your Nurse Practitioner Care Team Angela Puric, APRN-FPA, CNM Katy Bouyett, APRN, FNP-BC Nayely Cortes, APRN, AGNP Sarah Mathias, APRN, FNP-C Frequently Asked Questions: How much does the Liraglutide Medical Weight Loss Program cost and whats included in the price
Long-term success comes from the metabolic reprogramming that occurs when GLP pathways remain consistently activated, helping maintain results even after you complete your initial treatment protocol